Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy

  • Jerry R. Mendell
    Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, Ohio
  • Zarife Sahenk
    Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, Ohio
  • Kelly Lehman
    Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, Ohio
  • Carrie Nease
    Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, Ohio
  • Linda P. Lowes
    Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, Ohio
  • Natalie F. Miller
    Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, Ohio
  • Megan A. Iammarino
    Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, Ohio
  • Lindsay N. Alfano
    Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, Ohio
  • Amanda Nicholl
    Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, Ohio
  • Samiah Al-Zaidy
    Department of Pediatrics, The Ohio State University, Columbus
  • Sarah Lewis
    Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, Ohio
  • Kathleen Church
    Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, Ohio
  • Richard Shell
    Department of Pediatrics, The Ohio State University, Columbus
  • Linda H. Cripe
    Department of Pediatrics, The Ohio State University, Columbus
  • Rachael A. Potter
    Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, Ohio
  • Danielle A. Griffin
    Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, Ohio
  • Eric Pozsgai
    Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, Ohio
  • Ashish Dugar
    Sarepta Therapeutics Inc, Cambridge, Massachusetts
  • Mark Hogan
    Department of Radiology, Vascular and Interventional Radiology, Nationwide Children's Hospital, Columbus, Ohio
  • Louise R. Rodino-Klapac
    Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, Ohio

書誌事項

タイトル別名
  • A Nonrandomized Controlled Trial

収録刊行物

  • JAMA Neurology

    JAMA Neurology 77 (9), 1122-, 2020-09-01

    American Medical Association (AMA)

被引用文献 (2)*注記

もっと見る

問題の指摘

ページトップへ